Skip to main contentAll experts

DrGautam Kalyatanda

CLIN ASO PROF

MD-MEDICINE

Orcid identifier0000-0003-3334-614X (opens in a new tab)⁠
  • CLIN ASO PROF
    MD-MEDICINE

GRANTS

  • GRANT
    A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species
    F2g Limited1 Apr 2024 - 29 Jan 2026
    Closed
  • GRANT
    COVID-19 Rapid Assay
    Kaohsiung Medical University1 Mar 2021 - 31 Dec 2021
    Expired